Board Committees & Charters

Under the terms of its Charter, the Audit Committee meets at least 6 times a year, including periodic meetings held separately with management, the internal auditor, and the independent auditor. The Audit Committee represents and assists the Pfizer Board with the oversight of the integrity of the Company's financial statements and internal controls, the Company's compliance with legal and regulatory requirements, the independent auditor's qualifications and independence, the performance of the Company's internal audit function, and the independent auditor.

Under the terms of its Charter, the Compensation Committee is directly responsible for establishing annual and long-term performance goals, and objectives for our elected officers.

Under the terms of its Charter, the Governance & Sustainability Committee is responsible for considering and making recommendations to the Board concerning the appropriate size, function and needs of the Board.

The Executive Committee performs the duties and exercises the powers delegated to it by the Board of Directors.

Under the terms of its Charter, the Regulatory and Compliance Committee is primarily responsible for overseeing and reviewing the Company's healthcare law compliance programs and the status of compliance with laws, regulations, and internal procedures applicable to pharmaceutical sales and marketing activities.

The Science and Technology Committee was established in 2003. Under the terms of its Charter, the Committee is responsible for periodically examining management's direction and investment in the Company's pharmaceutical Research & Development as well as in its technology initiatives.

The Committee may meet privately with independent consultants and be free to speak directly and independently with any members of management in discharging its responsibilities.